Antonius Schuh, CEO at Trovagene, Inc. (TROV), bought 20,000 shares at $5.45 ($109K) on 2015-08-12, disclosed to the SEC on 2015-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.